Funded Tech Companies
Rheostat Therapeutics
Wondering who provided funding to Rheostat Therapeutics? AbbVie Biotech Ventures, Amgen Ventures and Mayo Medical Ventures joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Rheostat Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Company Background Information
Overview
Rheostat's mission is to invent novel treatments for neurodegenerative disease through modulation of mitophagy and autophagy. They believe that the degradation of toxic cellular components, whether they are damaged organelles or aggregated proteins, is a fundamental node of biology.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/27/2018
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joshua Resnick
Chief Scientific Officer
Magdalene Moran
Company Investors
- AbbVie Biotech Ventures
- Amgen Ventures
- Mayo Medical Ventures
- Alexandria Venture Investments
- Dementia Discovery Fund
- MRL Ventures
- SV Health Investors
Browse more funded tech companies:
Rheos Medicines | Rhetorical Systems
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs